Literature DB >> 34913472

Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis.

Zhang Zhang1, Huijun Sun2, Junzhi Hou3, Lili Li4, Lijuan Wu5.   

Abstract

BACKGROUND: Mounting evidence indicates that circular RNAs (circRNAs) play vital roles in human diseases, especially in cancers. However, the biological functions and underlying mechanism of circRNA fatty acid desaturase 2 (circFADS2) in cutaneous squamous cell carcinoma (CSCC) have not been reported.
METHODS: The expression levels of circFADS2, microRNA-766-3p (miR-766-3p) and homeobox A9 (HOXA9) were determined by quantitative real-time PCR (qRT-PCR). Flow cytometry analysis was used to determine cell cycle distribution. Cell proliferation was evaluated by Cell Counting Kit-8 (CCK-8) and colony formation assays. Wound healing and transwell assays were used to assess cell migration and invasion abilities. Glycolysis was examined via the measurement of extracellular acidification rate (ECAR). All protein levels were detected by western blot assay. The interaction between miR-766-3p and circFADS2 or HOXA9 was predicted by bioinformatics software and confirmed by dual-luciferase reporter, RNA pull-down, and RNA Immunoprecipitation (RIP) assays. The mouse xenograft model was established to investigate the role of circFADS2 in vivo.
RESULTS: CircFADS2 was downregulated in CSCC tissues and cells. CircFADS2 overexpression inhibited CSCC cell proliferation, metastasis and glycolysis. Moreover, miR-766-3p was able to directly bind to circFADS2, and circFADS2 played an anti-cancer role in CSCC by downregulating miR-766-3p. In addition, HOXA9 was a direct target of miR-766-3p, and miR-766-3p inhibition suppressed CSCC cell proliferation, metastasis and glycolysis by upregulating HOXA9. Furthermore, circFADS2 acted as a sponge of miR-766-3p to regulate HOXA9 expression. Besides, circFADS2 suppressed tumor growth in vivo.
CONCLUSION: CircFADS2 suppressed CSCC progression by regulating miR-766-3p/HOXA9 axis, which might provide a promising therapeutic target for CSCC.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34913472     DOI: 10.14670/HH-18-409

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  41 in total

Review 1.  Cutaneous squamous-cell carcinoma.

Authors:  M Alam; D Ratner
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  microRNAs: a newly described class of encoded molecules that play a role in health and disease.

Authors:  K Felekkis; E Touvana; Ch Stefanou; C Deltas
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

3.  Upregulated circular RNA circ_0070934 facilitates cutaneous squamous cell carcinoma cell growth and invasion by sponging miR-1238 and miR-1247-5p.

Authors:  Xiaoxia An; Xiguang Liu; Guozhang Ma; Chen Li
Journal:  Biochem Biophys Res Commun       Date:  2019-04-06       Impact factor: 3.575

4.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

Authors:  Penney M Gilbert; Janna K Mouw; Meredith A Unger; Johnathon N Lakins; Mawuse K Gbegnon; Virginia B Clemmer; Miriam Benezra; Jonathan D Licht; Nancy J Boudreau; Kelvin K C Tsai; Alana L Welm; Michael D Feldman; Barbara L Weber; Valerie M Weaver
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

5.  DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.

Authors:  Chen Chen; Sheng Xue; Jin Zhang; Wei Chen; Dongkui Gong; Jiayi Zheng; Junjie Ma; Wei Xue; Yonghui Chen; Wei Zhai; Junhua Zheng
Journal:  Int J Cancer       Date:  2017-08-08       Impact factor: 7.396

6.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Authors:  V Baldin; J Lukas; M J Marcote; M Pagano; G Draetta
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

7.  HOXA9 is Underexpressed in Cervical Cancer Cells and its Restoration Decreases Proliferation, Migration and Expression of Epithelial-to-Mesenchymal Transition Genes.

Authors:  Liliana Alvarado-Ruiz; Maria Guadalupe Martinez-Silva; Luis Alberto Torres-Reyes; Patricia Pina-Sanchez; Pablo Ortiz-Lazareno; Alejandro Bravo-Cuellar; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suarez
Journal:  Asian Pac J Cancer Prev       Date:  2016

8.  CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.

Authors:  Wen Bi; Jiayu Huang; Chunlei Nie; Bo Liu; Guoqing He; Jihua Han; Rui Pang; Zhaoming Ding; Jin Xu; Jiewu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-13

Review 9.  Circular RNAs in Cancer.

Authors:  Duc-Hiep Bach; Sang Kook Lee; Anil K Sood
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-16       Impact factor: 8.886

10.  Silencing circRNA_001937 may inhibit cutaneous squamous cell carcinoma proliferation and induce apoptosis by preventing the sponging of the miRNA‑597‑3p/FOSL2 pathway.

Authors:  Ling Gao; Hong-Juan Jin; Duo Zhang; Quan Lin
Journal:  Int J Mol Med       Date:  2020-09-10       Impact factor: 4.101

View more
  1 in total

Review 1.  Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.

Authors:  Fei Liu; Shenglong Li
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.